Psychedelic Startups, Biotech, Drug Discovery, Psilocybin, DMT, Psychedelics & Society | Sam Banister | 79
Mind & Matter
00:00
Are You Aiming to Get to the Point Where You Guys Will Be Doing Clinical Work?
We're largely a chemistry company, so am this huge amount of benefit in or getting your hands dirty with chemistry and learning sort of the details of these molecules. But we're doing l thepharmacology and with various partners, just beause it makes, it makes the most sense from a commercial perspective. So our plan is to take one of those, probably from product family one, to the clinic ourselves. And for psychoplacogens, its sort of that those effects have only been demonstrated to the animal level. So some clinical work still needs to be done there too.
Transcript
Play full episode
